News

Filter

Current filters:

None

8676 to 8685 of 97551 results

Alnylam's RSV drug candidate misses primary endpoint in Ph IIb

31-05-2012

Leading USA-based RNAi therapeutics firm Alnylam Pharmaceuticals (Nasdaq: ALNY) yesterday announced disappointing…

Alnylam PharmaceuticalsBiotechnologyResearchRespiratory and Pulmonary

BioAlliance's Sitavig NDA "receivable" by US FDA

30-05-2012

French biotech firm BioAlliance Pharma (Euronext Paris: BIO) has announced the receivability of its Sitavig…

Anti-viralsBioAlliance PharmaBiotechnologyNorth AmericaRegulationSitavigSitavir

Expanded Access Program for enzalutamide agreed with US FDA

30-05-2012

The US Food and Drug Administration agreed that Medivation (Nasdaq: MDVN) and Japanese drug major Astellas…

Astellas PharmaBiotechnologyenzalutamideMDV3100MedivationNorth AmericaOncologyPharmaceuticalRegulation

US legislation could block public access to drug safety information, claim consumer groups

30-05-2012

A provision in the Food and Drug Administration Reform Act that would block public access to potentially…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Diabetes drug shows promise for traumatic brain injury

30-05-2012

Although the death toll is relatively low for people who suffer from traumatic brain injury (TBI), it…

Diabetesexendin-4NeurologicalPharmaceuticalResearch

Japan High Court rules in favor of AstraZeneca over Iressa deaths

30-05-2012

Anglo-Swedish drug major AstraZeneca's (LSE: AZN) Japanese subsidiary has received a decision from the…

Asia-PacificAstraZenecaIressaLegalOncologyPharmaceutical

Vertex slumps as firm revises Kalydeco data

30-05-2012

The USA's Vertex Pharmaceuticals (Nasdaq: VRTX) saw its shares plunge 19% to $52.85 in early trading…

KalydecoPharmaceuticalRare diseasesResearchRespiratory and PulmonaryVertex

8676 to 8685 of 97551 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top